blood clots Akonni Bio Obtains FDA 510(k) Clearance for TruDiagnosis MDx System, PGx Test Akonni has received clearance for a molecular diagnostic instrument and a saliva-based pharmacogenomics test for warfarin metabolism. Genotyping Appears to Offer Warfarin Dosing Edge in New Clinical Trial Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing. U of Chicago Researchers Discover Novel Polymorphisms Associated With VTE in African Americans The research team found three novel polymorphisms on chromosome 20 associated with an increased risk of blood clots in populations of African descent. Meta-Analysis Implicates Two New Loci in Venous Thromboembolism Data from a dozen GWAS led researchers to venous thromboembolism-associated variants in the TSPAN15 and SLC44A2 genes. JAMA Study Questions Need for Genotype Testing for Clopidogrel Jun 21, 2011 FDA Declines Clearance of Nanosphere PMA for Plavix Metabolism Test Jun 21, 2011 Correction: Mayo Clinic, Rheonix Partner to Evaluate Warfarin Test Sep 2, 2010 New Data on CYP2C19 Loss-of-Function Alleles Questions Impact of Plavix PGx Testing Premium Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.